Merck Balance Sheet Health
Financial Health criteria checks 4/6
Merck has a total shareholder equity of $37.6B and total debt of $35.1B, which brings its debt-to-equity ratio to 93.1%. Its total assets and total liabilities are $106.7B and $69.0B respectively. Merck's EBIT is $4.6B making its interest coverage ratio 5.8. It has cash and short-term investments of $7.1B.
Key information
93.1%
Debt to equity ratio
US$35.06b
Debt
Interest coverage ratio | 5.8x |
Cash | US$7.09b |
Equity | US$37.64b |
Total liabilities | US$69.04b |
Total assets | US$106.68b |
Recent financial health updates
No updates
Recent updates
Merck's Future Brightens With Winrevair's Blockbuster Potential
Mar 27Merck: A High-Conviction Investment For Long-Term Growth
Feb 29Merck: Big Pharma Looks Stronger Than Ever Ahead Of 2023 Earnings
Jan 29Is Merck & Co., Inc. (NYSE:MRK) Trading At A 47% Discount?
Jan 26Merck's Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls
Jan 08Merck: One Of The Best - Unveiling The Trifecta Of Safety, Dividends, And Growth
Dec 25Merck (NYSE:MRK) Is Increasing Its Dividend To $0.77
Dec 08Financial Position Analysis
Short Term Liabilities: MRK's short term assets ($32.2B) exceed its short term liabilities ($25.7B).
Long Term Liabilities: MRK's short term assets ($32.2B) do not cover its long term liabilities ($43.3B).
Debt to Equity History and Analysis
Debt Level: MRK's net debt to equity ratio (74.3%) is considered high.
Reducing Debt: MRK's debt to equity ratio has reduced from 93.7% to 93.1% over the past 5 years.
Debt Coverage: MRK's debt is well covered by operating cash flow (37.1%).
Interest Coverage: MRK's interest payments on its debt are well covered by EBIT (5.8x coverage).